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Abstract
It is well-established that high levels of cAMP or glucose can produce insulin resistance. The aim of this study was to
characterize the interaction between these agents and insulin with respect to adipose tissue/muscle glucose transporter
isoform (glucose transporter 4, GLUT4) gene regulation in cultured 3T3-F442A adipocytes and to further elucidate the
GLUT4-related mechanisms in insulin resistance. Insulin (104 WU/ml) treatment for 16 h clearly increased GLUT4 mRNA
level in cells cultured in medium containing 5.6 mM glucose but not in cells cultured in medium with high glucose (25 mM).
8-Bromo-cAMP (1 or 4 mM) or N6-monobutyryl cAMP, a hydrolyzable and a non-hydrolyzable cAMP analog, respectively,
markedly decreased the GLUT4 mRNA level irrespective of glucose concentrations. In addition, these cAMP analogs also
inhibited the upregulating effect of insulin on GLUT4 mRNA level. Interestingly, the tyrosine phosphatase inhibitor
vanadate (1^50 WM) clearly increased GLUT4 mRNA level in a time- and concentration-dependent manner. Furthermore,
cAMP-induced inhibition of the insulin effect was also prevented by vanadate. In parallel to the effects on GLUT4 gene
expression, both insulin, vanadate and cAMP produced similar changes in cellular GLUT4 protein content and cAMP
impaired the effect of insulin to stimulate 14C-deoxyglucose uptake. In contrast, insulin, vanadate or cAMP did not alter
insulin receptor (IR) mRNA or the cellular content of IR protein. In conclusion: (1) Both insulin and vanadate elicit a
stimulating effect on GLUT4 gene expression in 3T3-F442A cells, but a prerequisite is that the surrounding glucose
concentration is low. (2) Cyclic AMP impairs the insulin effect on GLUT4 gene expression, but this is prevented by vanadate,
probably by enhancing the tyrosine phosphorylation of signalling peptides and/or transcription factors. (3) IR gene and
protein expression is not altered by insulin, vanadate or cAMP in this cell type. (4) The changes in GLUT4 gene expression
produced by cAMP or vanadate are accompanied by similar alterations in GLUT4 protein expression and glucose uptake,
suggesting a role of GLUT4 gene expression for the long-term regulation of cellular insulin action on glucose
transport. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Glucose di¡usion through the plasma membrane
into the cell interior is facilitated by glucose trans-
porters [1]. Several isoforms of glucose transporters
have been identi¢ed and they are distributed in a
tissue-speci¢c manner [1]. Insulin’s e¡ect to increase
glucose uptake is exerted by stimulating the trans-
location of glucose transporters from an intracellular
pool to the plasma membrane [2,3]. A main mediator
of glucose transport activation in the target tissues of
insulin is the adipose tissue/muscle glucose transport-
er isoform (GLUT4) [2,4,5]. In adipocytes, there is
also another isoform of glucose transporter, the so-
called erythrocyte/brain glucose transporter isoform
(GLUT1) which is located mainly at the plasma
membrane and considered to be responsible for basal
glucose transport [2,6].
Insulin resistance, i.e. impairment of insulin-stimu-
lated glucose uptake, is found in several disease
states, including diabetes mellitus, obesity and car-
diovascular diseases [7]. However, the mechanisms
of insulin resistance remain unclear [8]. Alterations
in insulin receptor (IR) binding and function, insulin
signal transduction as well as alterations in the trans-
location of GLUT4 and in the total number and
intrinsic function of GLUT4 could be involved. Pre-
vious studies in adipose tissue suggest that GLUT4
protein depletion in diabetic states is due to the sup-
pression of GLUT4 gene transcription [9,10]. The
results concerning the e¡ects of insulin are, however,
somewhat con£icting demonstrating either an in-
crease or a decrease in GLUT4 expression. In cul-
tured cells, insulin mainly was reported to exert a
downregulatory action, whereas in vivo it appears
to have a positive regulatory e¡ect. [9^11]. Thus,
the physiological regulation of GLUT4 gene expres-
sion as well as the mechanisms underlying the
observed GLUT4 depletion in adipose tissue in
insulin-resistant states are not fully understood.
Moreover, previous work showed that cAMP and
glucose may produce alterations in GLUT4 gene ex-
pression [12^14]. These factors can also play impor-
tant roles in insulin resistance [7,15,16]. Taken to-
gether, previous studies suggest that one possible
mechanism causing insulin resistance in adipose tis-
sue operates at the level of GLUT4 gene expression.
The 3T3-F442A cell line is an established model
for studying adipocyte gene regulation and metabo-
lism, since, after growing to con£uence, it is commit-
ted to di¡erentiate into mature adipocytes [17]. In the
process of di¡erentiation, gene expression for lipo-
genic enzymes, IRs and GLUT4 is initiated and
thereafter markedly increases [17,18]. Gradually,
these adipocytes accumulate triglyceride-containing
lipid droplets in the cytoplasm and obtain the phe-
notype of the mature adipocyte including insulin re-
sponsiveness. In order to study GLUT4 gene regula-
tion in adipocytes and to further elucidate the
cellular mechanisms for long-term insulin resistance,
we utilized cultured 3T3-F442A adipocytes as a mod-
el to dissect e¡ects of cAMP, insulin and glucose on
GLUT4 gene expression as well as the functional
consequences with respect to glucose transport. Con-
ventionally, adipocyte cultures have been performed
at a high non-physiological glucose concentration,
e.g. 25 mM [12^14,16], but we also wished to study
hormonal e¡ects at a lower, more physiological glu-
cose level. Thus, comparisons were made between
cells cultured in medium containing 5.6 and 25 mM
glucose, respectively. In addition, the role of IR gene
and protein expression as well as insulin binding
functions were also examined. The possible involve-
ment of tyrosine phosphorylation events in the regu-
lation of GLUT4 gene expression was elucidated by
using the tyrosine phosphatase inhibitor vanadate
[19].
2. Materials and methods
2.1. Materials
Sodium orthovanadate, 8-bromo-cAMP, guani-
dine thiocyanate, cesium chloride and 2-deoxy-D-glu-
cose (2-DOG) and bovine serum albumin (BSA) were
from Sigma Chemical Co. (St. Louis, MO, USA).
N6-monobutyryl cyclic AMP (N6-mbcAMP) was
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from Boehringer Mannheim (Mannheim, Germany)
and so was Klenow fragment. Human mono-
[125I]Tyr-A14-insulin (speci¢c activity 2 mCi/Wmol),
2-[1-14C]deoxy-D-glucose (14C-DOG, speci¢c activity
55 mCi/mmol) and enhanced chemiluminescence
(ECL) kit with a horseradish peroxidase-labelled
antibody were purchased from Amersham (Amer-
sham, UK). A polyclonal anti-IR L-subunit antibody
was from Transduction Laboratories (Lexington,
KT, USA). [K32P]dCTP (speci¢c activity 6 Ci/Wmol)
was from Du Pont (Geneva, Switzerland). Human
monocomponent insulin was purchased from Novo
Nordisk (Copenhagen, Denmark). Dulbecco’s modi-
¢ed Eagle’s medium (DMEM), fetal bovine serum
and new born bovine serum were from Gibco
BRL, Life Technologies (Paisley, UK). Human
GLUT4 cDNA plasmid and polyclonal GLUT4 anti-
body were generously provided by Dr. S. Cushman
(NIH, Bethesda, MD, USA). Human IR cDNA plas-
mid was kindly donated by Dr. G. Bell (University of
Chicago, Chicago, IL, USA). The 3T3-F442A mouse
cell line was originally obtained from Dr. H. Green
(Harvard University, Boston, MA, USA).
2.2. Cell culture
3T3-F442A preadipocytes were cultured in
DMEM containing 5.6 mM D-glucose supplemented
with 5% fetal bovine serum, 5% newborn bovine se-
rum and antibiotics (100 U/ml penicillin and 100 Wg/
ml streptomycin) in a humidi¢ed atmosphere of 5%
CO2 and 95% 02 at 37‡C. The culture medium was
replaced with fresh medium every 2^3 days. In some
experiments, the cells were cultured under the same
conditions as above but with a high glucose medium
(25 mM D-glucose). Note that the glucose concentra-
tions gradually fall during the cell culture and that
the indicated concentrations refer to the initial glu-
cose content in fresh medium. On day 8 after con-
£uence when the cells had become mature adipo-
cytes, the cells were treated for the indicated times
with cAMP analogs (hydrolyzable 8-bromo-cAMP
or non-hydrolyzable N6-mbcAMP), insulin, vanadate
either alone or in combination.
2.3. Northern blots
After the treatment, cells in 75 cm2 £asks were
washed twice with ice-cold PBS and immediately
solubilized in 4 M guanidine thiocyanate. Total
RNA was isolated by ultracentrifugation through
5.7 M cesium chloride according to Chirgwin et al.
[20]. The quantity of RNA in samples was spectro-
photometrically measured for the absorbance at
260 nm and the RNA purity was assessed by the
OD260=280 ratio (greater than 2). The RNA (30 Wg/
lane) was separated by electrophoresis under dena-
turing conditions in 1% agarose gels containing 18%
formaldehyde. The integrity and equal loading of
RNA were con¢rmed by visualization of ethidium
bromide-stained ribosomal RNA under UV lamp.
Transfer of RNA to nylon membranes was per-
formed as described by Maniatis et al. [21]. The
membranes were prehybridized for 2^4 h at 42‡C in
50% formamide, 10UDenhardts solution, 5Usodium
chloride^sodium citrate (SSC), 0.5% sodium dodecyl
sulfate (SDS) and 200 Wg/ml herring sperm DNA.
Hybridization was subsequently performed at 42‡C
over night in a fresh solution composed as the pre-
hybridization solution but addition of [K32P]dCTP-
labelled cDNA probes prepared by the random prim-
ing method. For GLUT4 Northern blots we used a
full length cDNA of human GLUT4 and for IR a
751 base (corresponding to nucleotides 1271^2021)
cDNA of human IR. Following hybridization, the
membranes were washed at 55‡C ¢rst with 2USSC
and 0.5% SDS for 1 h, then 0.6USSC and 0.5% SDS
for 30 min, 0.2USSC and 0.1% SDS for 15 min and
¢nally with 0.1USSC and 0.1% SDS for 15 min. The
membranes were exposed to Kodak X-Omat ¢lm at
380‡C for autoradiography.
2.4. Western blots
For estimation of the GLUT4 content of 3T3-
F442A adipocytes, total cellular membranes were
prepared [22]. Cells cultured in 35-mm 6-well plates
were washed twice with ice-cold PBS and harvested
into cold TES homogenization bu¡er (20 mM Tris^
HCl, 225 mM sucrose, 1 mM EDTA and 1 mM 4-(2-
aminoethyl)-benzene sulfonylphthalate) and were ho-
mogenized with 10 strokes of a motor-driven pestle.
Total membrane fraction were isolated by centrifu-
gation of the homogenate at 212000Ug for 60 min at
4‡C. The pellet was resuspended and centrifuged as
above. The ¢nal pellet was resuspended in the TES
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homogenization bu¡er and stored at 320‡C. Pro-
teins were separated by electrophoresis on 10%
SDS-polyacrylamide gel, transferred to nitrocellulose
membrane and immunoblotted with antibody against
GLUT4 and a secondary, horseradish peroxidase-la-
belled antibody. Immunoreactive proteins were visu-
alized using the ECL kits. The apparent molecular
weights of the peptides were determined by compar-
ison with protein standards.
For assessment of IR abundance, lysates of 3T3-
F442A cells were prepared. Cultured cells in 35-mm
6-well plates were washed twice with ice-cold PBS
and harvested in ice-cold cell lysate solution contain-
ing 25 mM Tris^HCl, 0.5 mM EDTA, 2 mM NaCl,
1% Nonidet NP-40, 10 mM NaF, 10 Wg/ml leupeptin,
1 mM benzamidine, 2 mM 4-(2-aminoethyl)-benzene
sulfonylphthalate. The cells were lysed at 4‡C for 1 h
during vigorous rocking. The cell lysate proteins
were subjected to electrophoresis, transferred and im-
munoblotted as described for GLUT4 but immuno-
blotted with an antibody against the IR L-subunit.
The bands obtained from Western and Northern
blots were quanti¢ed by measuring arbitrary units of
optical density (Bio-Rad GS-700 imaging densitom-
eter).
2.5. Cell surface 125I-insulin binding
Cultured cells in 24-well plates were washed twice
with DPBS containing 1% BSA, cell surface binding
of 125I-insulin (0.2 ng/ml) was performed at 4‡C for
4 h. At the end of the binding period, the cells were
brie£y washed three times with ice-cold DPBS and
were subsequently solubilized in 1% Triton X-100 at
37‡C for 20 min. Radioactivity was determined in
triplicate samples. Non-speci¢c binding was deter-
mined in the presence of 200 ng/ml insulin and was
subtracted.
2.6. 14C-deoxyglucose uptake
Cultured cells in 24-well plates were washed twice
with serum-free DMEM and incubated at 37‡C for
6
Fig. 1. E¡ects of insulin (A), vanadate (B) and cAMP (A, C)
on GLUT4 mRNA levels in 3T3-F442A adipocytes. Cells were
cultured in DMEM containing 5.6 mM glucose supplemented
with 5% newborn bovine serum and 5% fetal bovine serum un-
til day 8 after con£uence. The cells were then treated with the
indicated agents for 16 h or the indicated times. RNA was pre-
pared from the cells and Northern blot analysis of GLUT4
mRNA abundance was performed by using a full length cDNA
of human GLUT4 labelled with 32P. The results shown are
from one representative of 3^6 separate experiments. The
GLUT4 bands (2.7 kb) were quanti¢ed by measuring OD with
subtraction of background for each lane. The arbitrary units
obtained are expressed as percent of those from the basal con-
dition (no addition, left lane).
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2 h in order to avoid possible e¡ects of bovine serum
on DOG uptake. Then, the cells were washed twice
with PBS, and incubated in PBS in the presence of
the indicated agents at 37‡C for 10 min. Then, incu-
bation with or without insulin was carried out for
another 20 min. 14C-DOG (0.17 WCi/ml in the pres-
ence of 0.08 mM 2-DOG) was ¢nally added for 10
min. Non-speci¢c 14C-DOG trapping was determined
by adding 100 mM glucose together with 14C-DOG.
Glucose uptake was stopped by discarding the incu-
bation solution and immediately adding cold PBS.
The cells were washed with PBS three times. The
cells were solubilized with 1% Triton X-100 at 37‡C
for 20 min in a shaking water bath and radioactivity
was determined in triplicate samples in a scintillation
counter and non-speci¢c 14C-DOG trapping was sub-
tracted.
2.7. Statistics
Statistical signi¢cance of di¡erences was tested
with Student’s two-tailed t-test for paired data. Re-
sults are means þ S.E.M. unless otherwise indicated.
3. Results
3.1. E¡ects of insulin, vanadate and cAMP on
GLUT4 mRNA and protein levels
When 3T3-F442A adipocytes were cultured in
DMEM with 5.6 mM glucose, insulin treatment
(104 WU/ml) for 16 or 48 h clearly increased
GLUT4 mRNA levels, to 158 þ 9% (assessed by den-
sitometry) compared to control cells, n = 7,
P = 0.0008 (Fig. 1A). Incubation with the tyrosine
phosphatase inhibitor vanadate (10 WM) also clearly
increased GLUT4 mRNA levels (142 þ 12% n = 6,
P = 0.017). The time-course for the vanadate e¡ect
was studied. An increase in GLUT4 mRNA level
was demonstrated after 4 h of vanadate treatment,
reaching maximum at 24 h and with essentially no
e¡ect remaining at 48 h (Fig. 1B). The e¡ect of va-
nadate was also concentration-dependent with a bell-
shaped curve peaking at V10 WM (data not shown).
In contrast, incubation with 4 mM 8-bromo-
cAMP for 16 h produced a marked reduction in
GLUT4 mRNA level (60 þ 10% of control, n = 7,
P = 0.008, Fig. 1C). This e¡ect appeared to be
dose-dependent and a slightly less pronounced inhi-
bition was seen with 1 mM 8-bromo-cAMP. Also,
control experiments showed that the non-metaboliz-
able cAMP analog N6-mbcAMP had a similar e¡ect
as 8-bromo-cAMP (Fig. 1C). The insulin-stimulated
expression of GLUT4 mRNA was also inhibited in
the presence of cAMP analogues (Figs. 1A and 2A)
and insulin had no signi¢cant e¡ect in the presence
of cAMP analogues (GLUT4 mRNA 112 þ 34% of
cAMP alone, n = 6, NS). In contrast, vanadate (10
WM) in combination with insulin produced a clear
e¡ect on GLUT4 mRNA expression in cAMP-
Fig. 2. E¡ects of insulin, cAMP and vanadate, alone or in com-
binations, on GLUT4 mRNA (A) and protein levels (B) in
3T3-F442A adipocytes. Cells were cultured as in Fig. 1 with the
indicated agents for 16 h. (A) GLUT4 mRNA levels were as-
sessed as described in Fig. 1. One representative of three sepa-
rate experiments is shown. (B) GLUT4 protein content in total
cellular membranes was assessed by Western blot analysis. The
protein was separated by SDS-PAGE electrophoresis and im-
munoblot was performed by using a polyclonal antibody
against GLUT4 (45 kDa).
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treated cells, so that insulin+vanadate+8-bromo-
cAMP had 236 þ 28% of the amount of GLUT4
mRNA compared to 8-bromo-cAMP alone (n = 3,
P = 0.041, Fig. 2A).
In contrast, when cells were cultured in DMEM
containing 25 mM instead of 5.6 mM glucose, insulin
or vanadate treatment did not induce any increase,
but rather a decrease, in the GLUT4 mRNA level
(60 þ 18 and 46 þ 28% of basal, respectively, n = 3,
NS) and this is shown in Fig. 3. However, the inhib-
itory e¡ects of cAMP on GLUT4 mRNA levels were
still evident at this high glucose level (28 þ 9 and
25 þ 14% of basal for 1 and 4 mM 8-bromo-cAMP,
respectively, n = 3, P = 0.018 and 0.032, respectively).
To rule out possible non-speci¢c e¡ects on mRNA
levels we also assessed L-actin mRNA in the 3T3
cells. None of the employed modi¢cations of the
culture medium, i.e. insulin, vanadate, cAMP ana-
logs or glucose, had any e¡ects on L-actin mRNA
(data not shown).
To verify the e¡ects of insulin, vanadate and
cAMP on GLUT4 protein expression, experiments
using Western blots were performed to assess the
GLUT4 content of the total cellular membranes in
3T3-F442A cells. As shown in Fig. 2B, GLUT4 pro-
tein was altered essentially in parallel to the mRNA
Fig. 3. E¡ects of cAMP, insulin and vanadate on GLUT4
mRNA levels in 3T3-F442A adipocytes cultured at a high glu-
cose concentration. The experiments were performed as de-
scribed in Fig. 1, but the cells were cultured in DMEM con-
taining 25 mM glucose. One representative of three separate
experiments is shown.
C
Fig. 4. E¡ects of insulin,(A, C), cAMP (B, C) and vanadate (C)
on IR mRNA (A, B) and protein levels (C) in 3T3-F442A adi-
pocytes. Cells were cultured as described in Fig. 1 and treated
with the indicated agents for 16 h (or when indicated, 48 h).
(A, B) Total RNA (30 Wg/lane) from these cells was subjected
to Northern blot analysis by using a 751 base cDNA of human
IR labelled with 32P. Of the two bands representing IR mRNA
(7.8 and 9.5 kb), the 9.5 kb band was quanti¢ed with densitom-
etry. (C) Cell lysate protein (15 Wg/lane) was separated by SDS-
PAGE electrophoresis and subjected to Western blot analysis
by using a polyclonal antibody against the IR L-subunit (95
kDa). The results shown are from one representative of ¢ve (A
and B) or two (C) experiments.
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levels, i.e. an increasing e¡ect of both insulin and
vanadate whereas 8-bromo-cAMP reduced the e¡ect
of insulin on GLUT4 content. Vanadate again pre-
vented such an inhibiting e¡ect of 8-bromo-cAMP
on the GLUT4 protein expression.
3.2. E¡ects of insulin, vanadate and cAMP on IR
mRNA and protein levels
The regulation of those agents on IR mRNA levels
and protein content was also assessed. Neither insu-
lin (104 WU/ml), vanadate (0.5^10 WM) or the cAMP
analogs (1^4 mM) alone or in combination produced
any consistent alterations in IR mRNA content dur-
ing 16- (or 48-)h treatments (Fig. 4A,B and data not
shown, n = 4 or 5). Accordingly, IR protein content
in cell lysates was also unaltered following these
treatments (Fig. 4C).
3.3. E¡ects of insulin, vanadate and cAMP on
125I-insulin binding
The cells were treated with insulin, the cAMP ana-
logs alone or in combination for 16 h in medium
containing 5.6 mM glucose and 125I-insulin binding
was then performed. Insulin treatment (104 WU/ml)
reduced 125I-insulin binding at the cell surface by
V50% (P6 0.05, n = 6) as shown in Fig. 5. The
cAMP analogue N6-mbcAMP treatment (1 or 4
mM) alone increased insulin binding at the cell sur-
face by V50^60% (Fig. 5). Also when added togeth-
er with insulin, N6-mbcAMP appeared to increase
insulin binding compared to insulin treatment alone,
but this was not statistically signi¢cant (Fig. 5).
8-Bromo-cAMP exerted a similar, but somewhat
smaller, e¡ect as did N6-mbcAMP (data not shown).
Vanadate (10 WM) alone had no e¡ect on insulin
binding, whereas it appeared to further decrease in-
sulin binding when added in combination with insu-
lin (data not shown). Basal 125I-insulin binding did
not di¡er signi¢cantly between cells cultured in 5.6
mM compared to cells cultured in 25 mM glucose;
1.11 þ 0.25 pg/105cells (n = 6) vs. 1.28 þ 0.30 pg/
105cells (n = 3).
When the cells were cultured in medium with 25
mM D-glucose, similar e¡ects of insulin and cAMP
analogs on 125I-insulin binding were found as in 5.6
mM glucose medium (data not shown).
3.4. E¡ects of insulin, vanadate and cAMP on
14C-deoxyglucose uptake
A short-term (20 min) insulin treatment (105 WU/
ml) markedly increased 14C-DOG uptake by V4.5-
fold. This e¡ect of insulin was reduced by V50%
when cells were pretreated with 8-bromo-cAMP (1
or 4 mM) for 16 h (Fig. 6). However, basal glucose
uptake was increased by the 8-bromo-cAMP treat-
ment alone (V2-fold increase for 4 mM 8-bromo-
cAMP treatment, P6 0.05, n = 8, data not shown),
and thus, expressed in absolute numbers the maximal
insulin-stimulated glucose uptake was not signi¢-
cantly altered by the cAMP analogue. Vanadate pre-
treatment (0.01 mM) alone did not alter glucose up-
take, but it enhanced insulin-stimulated glucose
uptake (V30% increase, not shown). The impairing
e¡ects of the cAMP analogs on glucose uptake were
also found when the cells were cultured in medium
containing 25 mM glucose (data not shown). In ad-
dition, experiments with di¡erent glucose concentra-
tions during cell culture suggested that the maximal
e¡ect of insulin to stimulate glucose uptake was im-
paired by high glucose per se, 294 þ 59 vs. 458 þ 57%
Fig. 5. E¡ects of insulin and cAMP on cell surface binding of
125I-insulin in 3T3-F442A adipocytes. Cells were cultured as de-
scribed in Fig. 1 and treated with or without insulin (104 WU/
ml) or/and N6-mbcAMP at the indicated concentrations for
16 h. Cells were washed twice with DPBS containing 1% BSA
and cell surface binding of 125I-insulin (0.2 ng/ml) was per-
formed at 4‡C for 4 h. After washing and solubilizing the cells
in 1% Triton X-100, radioactivity was determined. Data are
mean þ S.E.M. from 2^6 separate experiments (*P6 0.05, com-
pared to the group without any treatment, i.e. no N6-mbcAMP
or insulin).
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of basal 14C-DOG uptake in 25 mM glucose (n = 5)
and in 5.6 mM glucose (n = 11), respectively
(P = 0.071), whereas non-stimulated glucose uptake
was not consistently a¡ected.
Short-term (20 min) treatment with cAMP ana-
logues also markedly inhibited the maximal glucose
uptake stimulated by insulin (105 WU/ml), whereas in
contrast to the long-term e¡ect basal glucose uptake
was not altered (data not shown).
4. Discussion
The present study demonstrates that insulin exerts
an upregulating e¡ect on GLUT4 mRNA level in
mature 3T3-F442A adipocytes. This e¡ect of insulin
is dependent on the glucose concentration surround-
ing the cells and it was seen at a low (5.6 mM) but
not at a high glucose (25 mM) concentration, sug-
gesting a suppressing e¡ect of glucose on insulin-in-
duced GLUT4 gene expression. Similar observations
were obtained by Chu et al. [12], who found an in-
creasing e¡ect of insulin on GLUT4 mRNA level in
3T3-L1 cells deprived glucose in the culture medium
and no such e¡ect of insulin at a high glucose (15
mM) concentration. However, con£icting results
showing an inhibitory e¡ect of insulin on GLUT4
mRNA level were also reported [11]. The reason
for these diverging observations is currently un-
known. One possibility may be the di¡erences in
culture conditions, in particular the glucose concen-
tration, as suggested in the present study. In addi-
tion, the e¡ect of insulin on GLUT4 gene expression
may also be in£uenced by other bioactive factors in
the culture medium. For example, a recent study
demonstrated the requirement of dexamethasone
for the upregulating e¡ect of insulin [23], suggesting
that the regulatory e¡ect of insulin on GLUT4 gene
requires adjuvant mechanisms.
The regulatory e¡ect of glucose per se on GLUT4
gene expression is not clari¢ed. Although a down-
regulating e¡ect of hyperglycemia on GLUT4 gene
expression is suggested by in vivo studies [9], no di-
rect inhibitory e¡ect of high glucose on GLUT4
mRNA level could be demonstrated and the
GLUT4 gene promoter does not seem to contain a
glucose-responsive element [6]. However, the lack of
e¡ect of insulin in a high glucose environment may
be partly due to the impairment of insulin signalling
produced by high glucose [24] i.e. the glucotoxic ef-
fect [25]. In vivo, glucose transporter function but
not expression was shown to be impaired by high
glucose per se in diabetic rats [26]. This is in agree-
ment with recent data on primary cultured rat adi-
pocytes indicating that high glucose per se decreases
insulin action on glucose transport but not via al-
tered GLUT4 expression, whereas long-term expo-
sure to high glucose in combination with high insulin
levels produced a reduction in GLUT4 abundance
(Bure¤n, J., Huixia, L., Lauritz, J. and Eriksson,
J.W., unpublished data). In contrast to insulin,
cAMP treatment decreased basal GLUT4 mRNA
level as was also previously shown by other investi-
gators [11,27]. Furthermore, the upregulating e¡ect
of insulin on GLUT4 gene expression found in the
present study was markedly inhibited by cAMP. The
Fig. 6. E¡ects of cAMP on insulin-stimulated 14C-DOG uptake
in 3T3-F442A adipocytes. Cells were cultured as described in
Fig. 1 and pretreated for 16 h without (a) or with 8-bromo-
cAMP, 1 mM (b), 4 mM (R). After washing and incubating
with serum-free DMEM for 2 h, insulin was then added as the
indicated concentrations for another 20 min. 14C-DOG uptake
was then carried out at 37‡C for 10 min. Data are means
þ S.E.M. from 2^8 separate experiments and are expressed as %
of non-insulin-stimulated uptake at the indicated 8-bromo-
CAMP treatment (*P6 0.05, **P6 0.01, compared to the cor-
responding point with insulin alone).
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inhibitory e¡ect of cAMP was consistently found in
both basal and insulin-treated cells and it occurred
independent of the prevailing glucose concentration.
These results support an inhibitory e¡ect of cAMP
on GLUT4 gene expression and they are compatible
with the previous ¢nding that there is a cAMP-re-
sponsive element located in the promoter region of
the GLUT4 gene [27].
The present results demonstrating inhibitory ef-
fects of high glucose and cAMP on the insulin-stimu-
lated GLUT4 gene expression emphasize the impor-
tance of studying the combined e¡ects of insulin and
other hormonal and metabolic factors to elucidate
the physiological regulation of GLUT4 gene expres-
sion. The critical interaction between glucose and
insulin in the regulation of GLUT4 gene expression
in adipose tissue is also suggested by some in vivo
studies. A decrease in GLUT4 gene and protein lev-
els was seen in insulin-de¢cient, hyperglycemic ani-
mals [6,9]. In contrast, an increased GLUT4 gene
expression was found in hyperinsulinemic animals
with normal blood glucose level but not in hyper-
insulinemic, hyperglycemic animals [9,28]. Therefore,
it is reasonable that insulin plays a physiological role
in maintaining a su⁄cient level of GLUT4 gene and
protein expression. The present results may reconcile
the discrepant ¢ndings on insulin e¡ects on GLUT4
expression demonstrated in vivo and in vitro, respec-
tively, and thus the suppressing e¡ect previously
shown in vitro could be explained by the supraphy-
siological glucose levels commonly used in cell cul-
tures. Thus, under pathophysiological situations as-
sociated with insulin resistance, e.g. hyperglycemia or
elevated cellular cAMP levels following L-adrenergic
stimulation, the entrancing e¡ect of insulin may be
impaired. Thus, the resulting depletion of GLUT4
protein in adipose tissue could be a mechanism lead-
ing to or maintaining insulin resistance.
The mechanisms governing the transcriptional reg-
ulation of GLUT4 gene expression are to a great
extent unknown. Previous results suggested that the
e¡ects of cAMP and insulin on GLUT4 gene expres-
sion are mediated by a¡ecting the phosphorylation
state of putative peptides involved in promoter reg-
ulation [27]. The results with vanadate in the present
study indicates that tyrosine phosphorylation-related
mechanisms may be involved in the upregulation of
GLUT4 gene expression. Cellular insulin action, in
general, is triggered through tyrosine phosphoryla-
tion of the L-subunit of IR, IR substrate-1 and other
early signalling peptides [29]. Both cAMP and high
glucose can impair the tyrosine kinase activity of IR
and subsequent phosphorylation events, although the
mechanisms leading to such impairment might be
di¡erent for cAMP and glucose [25,30,31]. Therefore,
some factors which are known to a¡ect insulin-
stimulated tyrosine phosphorylation appear to simi-
larly alter GLUT4 gene expression. This concept is
supported by the ¢nding that the potent tyrosine
phosphatase inhibitor vanadate [19] alone increased
GLUT4 mRNA level. It should be noted that 10 WM
vanadate is e¡ective in increasing the GLUT4
mRNA level but does not produce an insulin-like
e¡ect on glucose uptake. However, this concentra-
tion is su⁄cient for PTP inhibition and for enhanc-
ing tyrosine kinase activity [19,32^34]. In addition,
vanadate was also able to reverse the impairment
in insulin action on GLUT4 gene expression pro-
duced by cAMP, possibly by enhancing tyrosine
phosphorylation of IR or signalling peptides thus
overcoming the cAMP e¡ect [35^37]. The unique
ability of vanadate as opposed to insulin to override
cAMP-induced impairment of GLUT4 gene expres-
sion also suggests that its mechanisms of action are
partly di¡erent from those of insulin. Probably it can
bypass the IR via tyrosine phosphatase inhibition
[38] enhancing the activity of vanadate-speci¢c tyro-
sine kinases that amplify the insulin signal at the
postreceptor level [32,39], and this is accompanied
by an enhancement of insulin-stimulated glucose up-
take [37].
The gene and protein expression for IR was also
investigated. Previous studies concerning the e¡ect of
insulin on IR gene expression are inconsistent. A
reducing e¡ect of insulin on IR mRNA abundance
was reported in HepG2 cells [40] whereas no e¡ect of
insulin was demonstrated in studies on IM-9 lympho-
cytes [41]. Concerning vanadate, a previous study
reported an inhibitory e¡ect on IR expression in
vivo in livers from streptozotocin-diabetic rats as
well as in vitro in Fao hepatoma cells [42]. In the
present study, neither insulin, vanadate or the cAMP
analogs alone or in combination altered IR mRNA
levels or the total amount of IR protein. These re-
sults may indicate that the machinery for regulating
IR gene expression is di¡erent between di¡erent cell
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types. In addition, these results clearly suggest that
gene expression for GLUT4 and IR, respectively, is
di¡erently regulated. In accordance with the lack of
e¡ect of cAMP on IR gene expression, the promoter
region of IR gene, in contrast to that of the GLUT4,
does not contain a typical cAMP-responsive element
[43]. It should be pointed out that since both IR and
L-actin mRNA levels were unaltered by insulin, va-
nadate and cAMP, also the cell di¡erentiation pro-
cess and cell viability were probably left intact by
these agents. This supports a speci¢c action of these
agents on GLUT4 gene expression. It can not be
excluded, however, that the unresponsiveness to in-
sulin in cells cultured in a high glucose concentration
could be related to alterations in cell di¡erentiation
as compared to the low glucose cell culture. This
issue was not speci¢cally addressed, but the unaltered
insulin binding capacity may support that cell di¡er-
entiation was similar between those culture condi-
tions [44]. Previous work did not identify any clear
e¡ect on di¡erentiation by alterations in the culture
glucose concentration [45]. Moreover, in mature, pri-
mary cultured rat adipocytes we recently found sim-
ilar interactions between high glucose and insulin
with respect to GLUT4 expression (Bure¤n, J., Huix-
ia, L, Lauritz, J. and Eriksson, J.W., unpublished
data) as those presently reported, again supporting
that alterations in cell di¡erentiation are not in-
volved.
It is clear that cell-surface IR was downregulated
by long-term insulin treatment as demonstrated in
our receptor binding experiments and in studies by
other authors [46,47]. Both the mRNA level and the
total protein content for IRs were unaltered, and
thus a decrease of cell surface IR and an increase
in intracellular IR amount due to receptor internal-
ization is suggested rather than a reduced receptor
synthesis or an increased IR degradation. In con-
trast, the binding capacity of IRs was increased by
long-term cAMP treatment, and this may be compat-
ible with an impairment of the IR internalization
process. This is di¡erent from the short-term e¡ect
where cAMP impairs cell-surface insulin binding
[48,49]. Thus, in the present study neither cAMP
alone or in combination with insulin impaired the
binding capacity of IRs, suggesting that long-term
cAMP counterregulation of insulin action on
GLUT4 gene expression is not mediated at the IR
binding level.
In accordance with the the demonstrated altera-
tions in GLUT4 gene expression, the ability of insu-
lin to stimulate glucose uptake was impaired by long-
term cAMP treatment whereas it was enhanced fol-
lowing vanadate. In addition, alterations in insulin
signalling preceding translocation of GLUT4 to the
cell surface as well as an altered functional state of
transporters in the plasma membrane may also be
relevant [15,50,51]. In contrast, the long-term e¡ect
of cAMP to increase ‘basal’ glucose uptake could
well be due to a stimulating e¡ect on GLUT1 gene
and protein expression [1,10,13]. Short-term cAMP
treatment did not increase basal glucose uptake in
this study giving further support for this interpreta-
tion. Although IR binding at the cell surface and
GLUT1 content may be increased, nevertheless insu-
lin stimulation of glucose uptake is impaired by long-
term cAMP treatment, and this supports the impair-
ment in GLUT4 gene expression as a possible mech-
anism for this form of insulin resistance.
In conclusion, a novel ¢nding in this study is that
both insulin and vanadate increase GLUT4 expres-
sion at both the mRNA and protein levels in 3T3-
F442A cells cultured at a low glucose concentration
(5 mM) whereas the e¡ect of insulin was not seen at
a high glucose concentration (25 mM). This may ex-
plain why previous results in vivo and in vitro, re-
spectively, have been apparently discrepant, because
the in vitro e¡ects were generally studied at non-
physiological, high glucose levels. In addition,
cAMP inhibits GLUT4 gene expression, and it also
opposes the stimulating e¡ect of insulin. In contrast,
IR gene and protein expression is not altered by
either insulin, vanadate nor cAMP. Thus, the insu-
lin-signalling pathway at the postreceptor level may
be critical for the interaction between these agents
and GLUT4 gene regulation. Functional experiments
assessing insulin-stimulated glucose uptake show ef-
fects that are parallel to those for GLUT4 expres-
sion, i.e. enhancement following vanadate and im-
pairment following cAMP. Thus, insulin may exert
a maintaining e¡ect on GLUT4 gene expression to
optimize glucose transport under physiological con-
ditions. In contrast, cAMP and high glucose impair
the insulin e¡ect on GLUT4 gene expression, and
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this may be an important mechanism for cAMP-in-
duced insulin resistance and also a partial explana-
tion for glucotoxicity.
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